Thomas McCauley

Technik-/Wissenschafts-/F&E-Leiter bei OMEGA THERAPEUTICS, INC.

Vermögen: - $ am 30.04.2024

55 Jahre

Health Technology

Consumer Services

Retail Trade

Aktive Positionen von Thomas McCauley

Unternehmen	Position	Beginn	Ende
OMEGA THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.07.2019	-

Unternehmen	Position	Beginn	Ende
Zikani Therapeutics, Inc. Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.	Corporate Officer/Principal	01.09.2018	01.07.2019
TRANSLATE BIO, INC.	Corporate Officer/Principal	01.09.2016	01.04.2018
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA	Corporate Officer/Principal	01.04.2010	01.08.2016

The University of Alabama at Birmingham	Doctorate Degree
Cornell University	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
OMEGA THERAPEUTICS, INC.	Health Technology

Private Unternehmen	3
Zikani Therapeutics, Inc. Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Zikani Therapeutics, Inc. is a preclinical-stage company developing and commercializing novel therapeutics. The company was founded by Lawrence G. Miller and Andrew G. Myers in 2014 and is headquartered in Watertown, MA.	Retail Trade
Translate Bio, Inc. Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.	Health Technology
Shire Pharmaceuticals, Inc. Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA	Health Technology